J. Cristino

发表

A Natural Language Processing–Based Approach for Identifying Hospitalizations for Worsening Heart Failure Within an Integrated Health Care Delivery System

A. Go, S. Sung, N. Sanghera, 2021, JAMA network open.

RE: Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction

C. Ng, D. Trueman, J. Cristino, 2018, Journal of medical economics.

Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic

M. Kolek, M. Lothgren, J. Finek, 2017, Journal of medical economics.

Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis

N. Desai, D. Trueman, J. Cristino, 2022, American Journal of Cardiovascular Drugs.

Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review

K. Tolley, C. Proudfoot, L. Thakur, 2022, The European Journal of Health Economics.

Mapping the Kansas City Cardiomyopathy Questionnaire (KCCQ) Onto EQ-5D-3L in Heart Failure Patients: Results for the Japanese and UK Value Sets

J. Spertus, M. Hunger, J. Eriksson, 2020, MDM policy & practice.

Analysis of Worsening Heart Failure Events in an Integrated Health Care System.

A. Go, S. Sung, N. Sanghera, 2022, Journal of the American College of Cardiology.

Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis

N. Desai, D. Trueman, J. Cristino, 2022, American Journal of Cardiovascular Drugs.

The Budget Impact of Denosumab in the Treatment of Giant Cell Tumor of the Bone (Gctb) in Belgium.

Y. Qian, S. Vingerhoedt, V. Fikkert, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Low persistence with oral biphosphonate treatment in postmenopausal osteoporosis.

J. Branco, H. Canhão, J. Guerreiro, 2019, Acta reumatologica portuguesa.

Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study

R. Gautam, Siwei Wang, J. Cristino, 2023, American journal of preventive cardiology.

Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review

K. Tolley, C. Proudfoot, L. Thakur, 2022, The European Journal of Health Economics.

Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.

P. Natarajan, J. Plutzky, S. Tsimikas, 2023, Journal of the American College of Cardiology.

Parametric Simulation of Headache Day Frequency Using A Negative Binomial Distribution: A Case Study of Erenumab in Episodic Migraine

A. Brennan, S. Palmer, S. Sapra, 2016 .

THE COMPARATIVE EFFICACY OF INCLISIRAN, PCSK9 INHIBITING MONOCLONAL ANTIBODIES, AND EZETIMIBE FOR THE TREATMENT OF HIGH CHOLESTEROL IN ADULTS WITH OR AT RISK OF ASCVD: A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS

N. Desai, Hsiu-Ching Chang, R. Stoekenbroek, 2022, Journal of the American College of Cardiology.